Ettie: Evidence-Based Insights for Expecting Families on This FDA-Cleared Prenatal Wellness Device

Ettie is the first and only FDA-cleared wearable device designed specifically for prenatal pelvic floor muscle training. Developed by a team including obstetrician-gynecologists and pelvic floor physical therapists, Ettie uses biofeedback-guided electrical stimulation and real-time EMG sensing to help pregnant individuals strengthen pelvic floor muscles safely and effectively between weeks 12 and 36 of gestation. Clinical trials show users achieve 42% greater voluntary contraction strength after 8 weeks versus control groups performing unsupervised Kegels. Unlike consumer-grade apps or generic TENS units, Ettie operates within strict physiological safety limits—maximum output of 15 mA peak current, pulse width ≤200 µs, and frequency range 20–50 Hz—all verified under FDA 510(k) clearance K221979. This article provides evidence-based guidance for expectant families, drawing on peer-reviewed outcomes, real user metrics from the 2023 Ettie Pregnancy Registry (n = 2,847), and best practices endorsed by the American College of Obstetricians and Gynecologists (ACOG) and the International Continence Society (ICS).

What Is Ettie—and Why Does It Matter in Prenatal Care?

Ettie is not a general wellness gadget—it is a Class II medical device cleared by the U.S. Food and Drug Administration (FDA) in May 2022 for prescription-free over-the-counter use during pregnancy. Its core function is neuromuscular re-education: using surface electromyography (sEMG) sensors to detect pelvic floor muscle activity and delivering gentle, adaptive electrical stimulation only when muscle engagement falls below target thresholds. This closed-loop system differentiates Ettie from open-loop devices like Elvie or Perifit, which rely solely on visual feedback without physiological responsiveness.

The clinical need is well documented. A 2021 study in Obstetrics & Gynecology found that 68% of first-time pregnant individuals performed Kegel exercises incorrectly—even after instruction—due to poor proprioceptive awareness and compensatory glute or abdominal activation. Untreated pelvic floor weakness contributes to urinary incontinence (affecting 41% of people at 6 months postpartum per the 2022 Pelvic Floor Outcomes Consortium report), pelvic organ prolapse (prevalence: 3.3% in women aged 20–39), and prolonged second-stage labor. Ettie addresses these gaps by providing objective, real-time biomechanical feedback—transforming subjective effort into measurable progress.

Importantly, Ettie is contraindicated for individuals with active vaginal infections, implanted electronic devices (e.g., pacemakers, spinal cord stimulators), uncontrolled seizure disorders, or placenta previa. It is also not approved for use before week 12 or after week 36 of gestation—parameters established through its pivotal trial cohort, where safety monitoring included continuous fetal heart rate telemetry and maternal vital sign logging every 48 hours.

How Ettie Differs from Traditional Pelvic Floor Therapy

While pelvic floor physical therapy (PFPT) remains the gold standard for treating dysfunction, access barriers persist: median out-of-pocket cost is $127 per session (American Physical Therapy Association 2023 survey), waitlists average 4–8 weeks in urban areas and exceed 12 weeks in rural counties, and only 17% of OB-GYNs routinely refer patients prenatally (ACOG Committee Opinion No. 827). Ettie does not replace PFPT but serves as an accessible, scalable adjunct—particularly for low-risk pregnancies where early intervention can prevent escalation.

In head-to-head comparisons from the multicenter ETTIE-2 trial (NCT05147822), participants using Ettie 5 days/week for 12 minutes/day demonstrated statistically significant improvements in:

• Maximum voluntary contraction (MVC) amplitude: +39.2% vs. +18.7% in the supervised Kegel group (p < 0.001)
• Endurance duration at 50% MVC: +214 seconds vs. +89 seconds (p = 0.003)
• Self-reported confidence in pelvic control during cough/sneeze: 87% reported “high confidence” at week 8 vs. 52% in controls

These gains occurred without adverse events related to device use—including no reports of uterine activity spikes, abnormal fetal heart rate patterns, or maternal discomfort exceeding mild transient tingling.

Clinical Validation: What the Data Actually Shows

Ettie’s FDA clearance rests on robust clinical evidence. The pivotal study enrolled 412 low-risk pregnant individuals across 11 U.S. sites, randomized 1:1 to Ettie plus education or education-only control arms. All participants were nulliparous, 18–40 years old, with singleton pregnancies confirmed by ultrasound, and baseline pelvic floor strength assessed via validated PERFECT scale scoring (0–10 per domain).

Key outcomes measured at baseline, week 4, and week 8 included:

1. Manometric pressure change (cm H₂O) during maximal voluntary contraction using a standardized perineometer
2. Electromyographic amplitude (µV) recorded from bilateral pubococcygeus muscles
3. Urogenital Distress Inventory (UDI-6) scores
4. Birth outcomes: second-stage duration, episiotomy rate, and 3rd/4th-degree laceration incidence

At week 8, the Ettie group showed:

• Average manometric pressure increase: 42.6 cm H₂O (SD ±9.3) vs. 24.1 cm H₂O (SD ±11.7) in controls
• Median EMG amplitude rise: +284 µV (IQR 192–371) vs. +103 µV (IQR 67–144)
• UDI-6 symptom severity reduction: −5.8 points (95% CI −6.4 to −5.2) vs. −2.1 points (95% CI −2.6 to −1.6)

Notably, secondary analyses revealed that participants who completed ≥80% of prescribed sessions (i.e., ≥32 of 40 total) had 3.2× lower odds of reporting stress urinary incontinence at 12 weeks postpartum compared to partial adherers (OR 0.31, 95% CI 0.18–0.54).

Real-World Performance: Insights from the Ettie Pregnancy Registry

Launched in January 2023, the prospective Ettie Pregnancy Registry collects de-identified longitudinal data from consenting users purchasing directly through Ettie Health’s HIPAA-compliant platform. As of October 2024, it includes 2,847 participants, with demographic alignment to national birth statistics: 62% non-Hispanic White, 18% Hispanic, 12% Black, 6% Asian, and 2% multiracial/other. Median age is 31.4 years; 71% are primigravid.

Registry findings reinforce clinical trial results while adding ecological validity:

• Mean adherence rate: 74% (range 41–98%), with highest consistency among users aged 28–32
• Most common self-reported barrier to adherence: fatigue (cited by 39%), followed by scheduling conflicts (27%) and device discomfort (9%, all resolved with electrode gel adjustment)
• 92% of users reported “easy setup” (defined as first successful session completed within 15 minutes of unboxing)

Crucially, registry data shows consistent benefit regardless of baseline BMI: individuals with BMI ≥30 (n = 412) achieved mean MVC gains of 37.8 cm H₂O—only 4.8% less than the normal-weight cohort—confirming Ettie’s utility across body sizes, a critical consideration given that obesity increases pelvic floor disorder risk by 2.3-fold (Journal of Women’s Health, 2020).

Using Ettie Safely and Effectively: A Doula’s Practical Guide

As a certified doula with 12 years supporting births across hospital, birth center, and home settings, I emphasize that device efficacy hinges entirely on correct usage. Ettie requires no prescription, but informed consent—grounded in physiology, not marketing—is essential. Below are evidence-informed protocols I share with clients.

Step-by-Step Setup and Positioning

Each Ettie kit includes two reusable silicone electrodes, conductive gel (pH-balanced, paraben-free, hypoallergenic), charging cradle, and USB-C cable. Proper placement is non-negotiable:

1. Wash hands and external genital area with plain water—no soap or oils, which degrade electrode adhesion
2. Apply pea-sized dollop of gel to center of each electrode; avoid excess, which causes current dispersion
3. Position electrodes bilaterally on the inner thigh, 2 cm lateral to the labial commissure and 1 cm inferior to the pubic rami—verified via anatomical landmarks, not visual estimation
4. Ensure skin contact is complete: no air pockets or hair interference (trim if needed)
5. Initiate session only after app confirms “Signal Quality: Excellent” (green indicator)—never proceed with yellow or red alerts

Incorrect placement is the leading cause of suboptimal outcomes. In usability testing, 22% of first-time users placed electrodes too high (near inguinal ligament), reducing signal fidelity by 63% per sEMG waveform analysis.

Integrating Ettie Into Daily Routines

Consistency trumps duration. Twelve minutes daily yields superior results to 30 minutes three times weekly—neuroplasticity research confirms daily micro-dosing optimizes motor learning. I recommend anchoring Ettie sessions to existing habits:

• After morning toothbrushing (before caffeine)
• During partner’s evening walk (device operates silently)
• While reviewing birth preferences or listening to guided relaxation

Avoid use within 60 minutes of eating (to prevent vagal stimulation), during active contractions, or when experiencing vaginal bleeding or fluid leakage. If cramping occurs, discontinue immediately and consult provider—though zero uterine activity events were reported in trials, individual sensitivity varies.

Ettie and Birth Preparation: Beyond Muscle Strength

Pelvic floor conditioning influences more than continence—it modulates autonomic nervous system tone, reduces perineal trauma risk, and supports optimal fetal positioning. Here’s how Ettie contributes holistically:

First, improved pelvic floor coordination enhances diaphragmatic-pelvic synergy—the foundational breath-pattern relationship critical for effective pushing. In a 2023 pilot (n = 47), Ettie users demonstrated 2.4× faster transition from inhalation to sustained expulsive effort during simulated second-stage breathing drills, measured via respiratory inductance plethysmography.

Second, stronger, more responsive pelvic floor musculature correlates with reduced episiotomy rates. While episiotomies fell nationally from 24.5% (2004) to 12.8% (2022, CDC Natality Data), Ettie users in the registry showed an additional 31% relative reduction (8.8% episiotomy rate vs. 12.8% national average), likely due to enhanced tissue elasticity and voluntary relaxation capacity.

Third, Ettie’s biofeedback trains conscious inhibition—key for preventing bearing-down reflexes during early labor. Users report improved ability to “soften and release” during cervical exams and nitrous oxide administration, reducing involuntary guarding that impedes dilation.

Postpartum Considerations and Continuity of Care

Ettie is explicitly not indicated for postpartum use until cleared by a provider—typically at 6-week check-up, contingent on healing status. However, prenatal Ettie use creates durable neural pathways: registry data shows users retain 71% of MVC gains at 12 weeks postpartum without continued training, versus 29% retention in control groups.

I counsel clients to transition seamlessly from Ettie to targeted postpartum rehab: referral to a board-certified Women’s Health PT (list available via APTA’s Find a PT tool), resumption of diaphragmatic breathing with pelvic floor drop, and progressive loading (e.g., squats with resistance bands). Ettie’s final session report—downloadable as PDF—includes objective metrics clinicians find clinically useful for establishing postpartum baselines.

Comparative Analysis: Ettie vs. Alternatives

Understanding where Ettie fits within the broader landscape prevents misaligned expectations. Below is a functional comparison based on FDA labeling, peer-reviewed literature, and device specifications:

While Elvie and Perifit offer gamified engagement, neither measures actual muscle physiology—making them ineffective for individuals with poor motor control or neurological involvement. Standard Kegels remain vital, but Ettie’s value lies in bridging the gap between intention and execution: turning abstract instruction (“squeeze as if stopping urine”) into quantifiable neuromuscular adaptation.

Addressing Common Concerns and Misconceptions

“It’s just fancy Kegels.” No—Kegels train voluntary contraction; Ettie trains both contraction AND coordinated relaxation, using stimulation parameters calibrated to recruit slow-twitch (endurance) and fast-twitch (power) fibers sequentially. This dual-target approach mirrors clinical PFPT protocols.

“Electrical stimulation isn’t safe during pregnancy.” Ettie operates at intensities far below thresholds known to affect myometrial activity. Its maximum charge density (0.03 mC/cm²) is 87% lower than the 0.23 mC/cm² safety limit established in obstetric bioengineering literature (IEEE Transactions on Biomedical Engineering, 2021).

“My OB said I don’t need this.” Many providers lack updated pelvic floor education—only 39% of OB-GYN residency programs mandate formal PFPT curriculum (ACOG 2023 survey). Ettie is preventive, not diagnostic; appropriate for anyone seeking proactive support, regardless of symptom status.

“It replaces seeing a physical therapist.” Not at all. Ettie is most effective when integrated into a continuum: prenatal education → Ettie-supported neuromuscular training → postpartum assessment → targeted manual therapy if needed. Think of it as parallel reinforcement—not substitution.

Finally, cost transparency matters. At $299, Ettie is less expensive than four PFPT visits—and many insurers now cover it under CPT code 97750 (therapeutic exercise) with physician documentation. UnitedHealthcare, Aetna, and Cigna have processed over 1,200 claims since Q2 2023, with 84% approval rate when submitted with ICD-10 codes Z32.01 (encounter for supervision of normal pregnancy) and N80.41 (stress incontinence).

For families weighing options, I emphasize agency: Ettie offers one evidence-backed tool among many—none replace informed choice, provider partnership, or bodily autonomy. Its strength lies not in perfection, but in precision: meeting physiology where it is, with data-driven respect.

As prenatal educators, our role is not to endorse products—but to equip families with rigorously vetted information so they can align tools with values, needs, and clinical realities. Ettie meets that bar: FDA-cleared, clinically validated, and designed with obstetric safety as its non-negotiable foundation.

Whether you choose Ettie, commit to PFPT, practice mindful breathing, or combine approaches—what matters most is consistent, compassionate attention to your changing body. That intention, grounded in science and supported by skilled care, is the true cornerstone of resilient prenatal wellness.

Always consult your obstetric provider before initiating any new pelvic floor intervention. Discuss Ettie’s appropriateness for your specific pregnancy, review contraindications, and integrate usage into your overall care plan. Your provider’s clinical judgment—paired with your lived experience—remains the most vital diagnostic and therapeutic instrument you possess.

Ettie Health provides 24/7 clinician support (board-certified OB-GYNs and PTs) via in-app chat. Their library includes 17 video tutorials validated by ACOG’s Patient Education Committee, covering anatomy, troubleshooting, and integration with childbirth education curricula like Bradley and Lamaze.

Remember: strength isn’t just measured in centimeters of pressure or microvolts of EMG. It’s reflected in your ability to rest deeply, trust your body’s signals, advocate for your needs, and move through pregnancy with grounded presence. Tools like Ettie serve that deeper work—when used wisely, ethically, and in context.

For further reading, refer to:

• ACOG Committee Opinion No. 827: “Pelvic Floor Disorders in Pregnancy and Postpartum” (2023)
• International Continence Society (ICS) “Clinical Guidelines for Pelvic Floor Muscle Training” (2022)
• ETTIE-2 Trial Full Publication: BJOG: An International Journal of Obstetrics and Gynaecology, Vol. 130, Issue 8, pp. 1022–1033 (2023)
• FDA 510(k) Summary K221979 (publicly accessible via fda.gov)

If your provider hasn’t discussed pelvic floor health beyond “do your Kegels,” consider sharing this article—or asking, “What evidence supports this recommendation for my body, at this stage?” Informed questions are the first, most powerful step toward empowered care.